Whereas after tumor cell invasion, osteoclastogenesis is promoted by the release of osteoprotegerin (OPG) and cytokines (IL6, IL15 etc.), leading to bone destruction [29]. The gene discussed is TNFRSF11B; the disease is neoplasm.